NCT07600359 Comparative Effects of Autogenic Inhibition and Reciprocal Inhibition Technique on Pain, Functional Disability and Gait in Sacroiliac Joint Dysfuction.
| NCT ID | NCT07600359 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Sacroiliac Joint Dysfunction |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-05-15 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-05-15 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sacro-iliac joint act as the shock absorber of the body. It is responsible for transferring vertical load of the whole body to lower limb hence contributing to stability of pelvic girdle. However, SI joint dysfunction is one of the most common causes of low back pain among the patients suffering from non-radicular low back pain. There can be a mechanical source which is due to muscle insufficiency or instability or a non-mechanical source which is osteoarthritis, infection or any trauma. It is thought to affect females more commonly with prevalence of about 46.71% in females and with the prevalence of about 15 to 30% in general. This poses great threat to bio mechanics of the body which can significantly lead to disability that can affect mobility, daily activities and quality of life of the individual. According to a study the pain caused by SIJD caused activity limitation and participation restriction of about 25% of the individuals. Hence making it difficult for them to continue their jobs. increased pain leads to worsening of the ability to perform ADLs which ultimately effects the quality of life. Altered biomechanics also leads to alteration in spatio temporal gait parameters.This study aims to compare the effects of autogenic inhibition technique and reciprocal inhibition technique in addition with conventional therapy in reliving low back pain, improving functional disability and alteration in spatio-temporal gait parameters in patients with sacroiliac joint dysfunction. Patients with SIJD will be recruited and will be randomly divided into two groups 20 in each group. Group 1 will receive autogenic inhibition technique of iliopsas, hamstrings, erector spinae and piriformis muscles along with standard core stabilization exercises and group 2 will receive reciprocal inhibition technique on iliopsas, hamstrings, erector spinae and piriformis muscles along with standard core stabilization exercises. The treatment will be continued for 3 weeks with 4 sessions of 25 minutes per week.
Eligibility Criteria
Inclusion Criteria: * Patients having low back pain greater than 4 weeks * Patients with positive gaenslen's test, thigh thurst test, standing flexion test, sacral compression and distraction test. * Patients not having any other condition that can affect gait * 25-45 years * Both males and females Exclusion Criteria: * Patients having nonspecific low back * Patients with lumbosacral fusion * Patients with any neurological condition * Patients with history of trauma of spine * Patients with any other lumbar spine condition (lumbar radiculopathy, spinal stenosis, spondylolisthesis, inflammatory arthritis) * Patients with any hip joint pathology * Patients using any assistive device
Contact & Investigator
Fajar Sajjad, DPT
PRINCIPAL INVESTIGATOR
Foundation University Islamabad
Frequently Asked Questions
Who can join the NCT07600359 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 45 Years, studying Sacroiliac Joint Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07600359 currently recruiting?
Yes, NCT07600359 is actively recruiting participants. Contact the research team at fajarsajjad1999@gmail.com for enrollment information.
Where is the NCT07600359 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07600359 clinical trial?
NCT07600359 is sponsored by Foundation University Islamabad. The principal investigator is Fajar Sajjad, DPT at Foundation University Islamabad. The trial plans to enroll 40 participants.